Start with the exact manufacturer, model, labeling, and unit identity, then trace the relevant FDA record and intended use. Registration, listing, clearance, approval, and authorization are different concepts. Preserve the evidence and resolve mismatches with qualified reviewers; a database match does not establish unit condition, lawful operator roles, or every advertised use.
What question should the buyer ask first?
Ask what device is actually being acquired and what services the business uses it to provide. A sales brochure, invoice description, or front-desk nickname may not identify the precise manufacturer, model, configuration, labeling, and intended use. Begin with the physical unit and original records.
The diligence task is not to declare the device safe for every person or to recommend treatment. It is to verify the seller’s regulatory claims and route unresolved questions to qualified technical, regulatory, and clinical reviewers. The buyer needs to know what evidence supports the proposed operating plan.
Do not assume that a purchase agreement representation resolves an uncertain device. Contractual remedies and operational feasibility are different. A buyer should understand the issue before relying on the unit to generate revenue after closing, particularly when it is central to the practice’s service mix.
How do registration, clearance, and approval differ?
The FDA explanation of device registration and certification claims makes a critical distinction: establishment registration and device listing do not denote approval, clearance, or authorization. FDA also explains that it does not issue device registration certificates. A decorative certificate is therefore not a substitute for the relevant regulatory evidence.
Different review pathways use different terminology. The buyer should preserve the actual record and use its terminology rather than call every device “FDA approved.” Some device categories may have exemptions or other requirements, so the absence of a familiar clearance number should be investigated rather than interpreted without context.
| Evidence | What to investigate | What it does not establish alone |
|---|---|---|
| Registration or listing | Relevant establishment and device entry | Approval, clearance, or authorization |
| Clearance or approval record | Exact device and applicable labeling | Condition of the used unit |
| Manufacturer labeling | Intended use and limitations | Every advertised service claim |
| Invoice and serial number | Unit identity and chain of ownership | Professional authority to operate |
Which identity documents should be collected?
Request photographs of labels, model and serial numbers, manufacturer information, original invoice, installation records, manuals, software version where relevant, attachments, and service history. Record the location and owner of each unit. Preserve the source and date of every identifier.
Check whether an accessory, handpiece, software feature, or imported configuration changes the analysis. A broad device family can contain different models and uses. A reseller’s description may omit that distinction, so match the actual unit rather than relying on an attractive product name.
Do not alter labels, open equipment, or perform technical tests beyond qualified authority merely to complete diligence. Ask the appropriate technical reviewer to define safe inspection and verification. If identity remains uncertain, document that uncertainty and its effect on the proposed acquisition rather than creating a confident but unsupported match.
How should the FDA search be performed?
- Record exact manufacturer and device identifiers from the unit and documents.
- Search the appropriate official FDA resource using those terms.
- Open the underlying record and relevant labeling, not only a search snippet.
- Compare model, manufacturer, intended use, and related identifiers.
- Preserve the record URL, document, access date, and comparison notes.
- Escalate missing or conflicting evidence to qualified reviewers.
The Devices@FDA catalog is an official starting point for approved and cleared device information. The FDA’s consumer guidance also points to other pathways and databases where relevant. The reviewer should use the resource appropriate to the device rather than assume one search interface covers every regulatory question.
A no-result search is an exception to investigate. Spelling, historical manufacturer names, acquired brands, model variants, and pathway differences can affect results. Conversely, one similar result is not proof that the actual unit and its advertised services match that record.
How do intended use and advertising fit together?
Compare the record and labeling with the business’s website, menus, staff descriptions, training, and services actually provided. The FDA aesthetic-device resources organize relevant device categories and regulatory information. They do not validate a particular med spa’s entire marketing program.
Record each material claim and the evidence offered for it. A device may have a supported status for a defined use while the business advertises broader benefits. The buyer should have qualified reviewers assess the actual discrepancy and appropriate response rather than rewrite claims based only on a broker’s interpretation.
Keep financial projections separate from clinical and regulatory assertions. A sales pitch that a device “can generate” a certain revenue does not establish demand, capacity, contribution, permission, or outcomes. Historical earned revenue and service costs need independent verification through financial and operating records.
What should the exception log show?
| Field | Example question |
|---|---|
| Identity issue | Does the label match the cited model? |
| Source conflict | Does the seller cite listing as approval? |
| Use question | Does advertised use match reviewed evidence? |
| Required reviewer | Who is qualified to resolve the issue? |
| Evidence needed | What manufacturer or regulatory document is missing? |
| Decision effect | Does this change operation, budget, timing, or closing? |
Distinguish confirmed facts, unresolved questions, and adviser conclusions. A missing document is not automatically a violation, while a confident seller explanation is not proof. Assign owners and deadlines, preserve responses, and state what remains uncertain at the decision date.
A financial holdback cannot by itself establish that the buyer can operate the device. If a critical issue remains unresolved, the parties need a supported contractual and operational response, which may include more investigation, changed scope, delay, or stopping the acquisition.
What does a clean database match leave unanswered?
The buyer still needs condition, maintenance, service support, software, supplies, warranties, liens, ownership, insurance, operator qualifications, professional oversight, facility requirements, and ordinary operating capacity. These questions involve different evidence and may require different advisers.
The California Medical Board’s medical spa guidance illustrates state-specific professional-role issues. FDA status is not a nationwide license for any employee or owner to perform any procedure. Local healthcare counsel and clinical leadership must assess the actual providers, services, and structure.
Do not make the opposite mistake of treating qualified staff as proof of device status. A provider license and a device record answer different questions. The acquisition file should show how both were investigated, together with technical and commercial support, before the buyer treats the service line as reliably transferable.
How can the buyer budget an unresolved finding?
Build an explicit scenario rather than a generic percentage discount. Identify the affected service contribution, qualified reviewer costs, possible downtime, replacement or inspection spending, customer obligations, staffing impact, and available alternatives. Use actual quotes and evidence where possible, labeling assumptions clearly.
Do not forecast continued device revenue while simultaneously assuming the unit cannot be used during review. If the timetable changes, refresh working capital and debt-service planning. The value issue may be smaller than the operational interruption, or vice versa; the model should expose both.
The seller should receive a precise request and an opportunity to provide supporting evidence through the agreed process. The buyer’s aim is a defensible decision, not a dramatic label based on an incomplete search. A documented resolution is more useful than a vague assurance that “FDA is fine.”
What is the final acquisition file?
Retain the unit register, source records, labeling comparison, exception log, manufacturer responses, qualified reviews, and closing treatment. Use the buyer roadmap, operations hub, valuation guidance, and seller hub. The diligence guide, professional responsibility guide, and Four-Number Med Spa Valuation Screen connect verification with operations and earnings.
The result should say what was matched, what the evidence supports, what it does not answer, and what remains open. That is more decision-useful than a single approval checkbox with no identity, intended-use comparison, or source trail.
What else do owners and buyers ask?
Does FDA registration mean a device is approved?
No. FDA explains that establishment registration and device listing do not denote approval, clearance, or authorization, and it does not issue device registration certificates. Identify the exact unit and relevant pathway, then verify the actual regulatory record and labeling. A certificate or listing entry is not a substitute for that analysis.
What if the device name produces no FDA search result?
Investigate rather than draw an immediate conclusion. Check exact model, manufacturer, historical names, configuration, spelling, and the appropriate pathway or database. Preserve the search and request original documentation. Qualified regulatory and technical reviewers should resolve the uncertainty before the buyer relies on the device’s proposed use and revenue.
Does an official device record authorize every med spa employee to use it?
No. Device regulatory status and professional authority are separate questions. The actual state, service, provider license, delegation, supervision, facility, and ownership structure need qualified review. A database match does not establish that every proposed operator or clinical arrangement is permitted, and a provider license does not independently prove device status.
Can the buyer rely on the seller’s FDA representation alone?
A contractual representation can allocate risk but does not replace verification of a critical operating asset. Obtain unit identifiers, source records, labeling, and qualified review of discrepancies. The buyer should understand what the evidence supports before closing, particularly if the service line depends on continued use of that specific device.
Which sources support this guide?
Sources were checked during research. Regulations, lender policies, and market conditions can change. Use the linked primary material and your advisors to confirm applicability.
- FDA registration is not device approval, clearance, or authorization — U.S. Food and Drug Administration
- Devices@FDA approved and cleared device information — U.S. Food and Drug Administration
- Aesthetic and cosmetic devices — U.S. Food and Drug Administration
- Medical spas: ownership and qualified personnel — Medical Board of California
Educational analysis prepared with AI-assisted research for The Med Spa Broker. “Last reviewed” records the source and editorial check date; it does not imply review by an attorney, clinician, or independent appraiser. Read our editorial standards.